Thromb Haemost 2003; 90(03): 465-475
DOI: 10.1160/TH03-02-0072
Platelets and Blood Cells
Schattauer GmbH

A tetrameric glycoprotein Ib-binding protein, agglucetin, from Formosan pit viper: structure and interaction with human platelets

Wen-Jeng Wang
1   Division of Biomedical Science, Department of Nursing, Chang-Gung Institute of Technology, Kwei-Shan, Tao-Yuan, Taiwan
,
Qing-Dong Ling
2   Cathay Medical Research Institute, Cathay General Hospital, Taipei, Taiwan
,
Ming-Yi Liau
3   Department of Biotechnology, Fooyin Institute of Technology, Ta-Liao, Kaohsiung Taiwan
,
Tur-Fu Huang
4   Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
› Author Affiliations
Financial support: This work was financially supported by grants from the National Science Council of Taiwan (NSC91-2320-B002-156) and Chang Gung Medical Research foundation (CMRPF32001).
Further Information

Publication History

Received 04 February 2003

Accepted after revision 25 May 2003

Publication Date:
05 December 2017 (online)

Summary

Agglucetin, a tetrameric agglutination inducer from the Formosan pit viper, has been identified as a platelet membrane glycoprotein (GP) Ib agonist and directly agglutinated fixed-platelets in the absence of von Willebrand factor (vWf). Here, we resolved the complete cDNA sequences of agglucetin subunits (α1, α2, β1 and β2) by molecular cloning. Each cloned cDNA encoding the leader peptide (23 residues) and the mature subunit (131/135/123/126 residues) shares a high degree of homology to each other and the C-type lectin-like GP Ib-binding proteins (BPs). Furthermore, agglucetin specifically caused platelet agglutination and surface exposure of integrin αIIbβ3 with a GPIb-dependent manner in washed platelets, based on the observation that the enhanced expression of functional αIIbβ3 was suppressed by a GPIb-cleaving metalloproteinase, crotalin. Pretreating platelets with staurosporine or BAPTA-AM also completely blocked the exposure of functional αIIbβ3, suggesting that the activation of protein kinase C and intracellular calcium mobilization are involved in the GPIb-dependent signaling. In human platelet-rich plasma (PRP), agglucetin elicited sequential biphasic responses of platelet agglutination and aggregation in a GPIb- and αIIbβ3-dependent manner, respectively, implying that other cofactors may amplify platelet activation to trigger aggregation.

The nucleotide sequences reported in Figs. 1 and 2 have deposited in the GenBank, EMBL and DDBJ Nucleotide Sequence Databases under the accession numbers: AF540645 for agglucetin-α1 subunit, AF540646 for agglucetin-α2 subunit, AF540647 for agglucetin-β1 subunit and AF540648 for agglucetin-β2 subunit.

 
  • References

  • 1 Wang WJ, Huang TF. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus acts as a glycoprotein Ib agonist. Thromb Haemost 2001; 86: 1077-86.
  • 2 Andrews RK, Berndt MC. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 2000; 8: 775-91.
  • 3 Fujimura Y, Kawasaki T, Titani K. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 1996; 76: 633-9.
  • 4 Navdaev A, Clemetson JM, Polgar J. et al. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to α2β1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ2, but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor. J Biol Chem 2001; 276: 20882-9.
  • 5 Kowalska MA, Tan L, Holt JC. et al. Alboaggregins A and B-structure and interaction with human platelets. Thromb Haemost 1998; 79: 609-13.
  • 6 Taniuchi Y, Kawasaki T, Fujimura Y. The high molecular mass, glycoprotein Ib-binding protein flavocetin-A induces only small aggregates in vitro. Thromb Res 2000; 97: 69-75.
  • 7 Taniuchi Y, Kawasaki T, Fujimura Y. et al. Flavocein-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim Biophys Acta 1995; 1244: 331-8.
  • 8 Sakurai Y, Fujimura Y, Kokubo T. et al. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom. Thromb Haemost 1998; 79: 1199-207.
  • 9 Navdaea A, Dormann D, Clemetson JM. et al. Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMκ responsible for platelet agglutination in plasma and inducing signal transduction. Blood 2001; 97: 333-41.
  • 10 Peng M, Lu W, Beviglia L. et al. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993; 81: 2321-8.
  • 11 Fujimura Y, Ikeda Y, Miura S. et al. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost 1995; 74: 743-50.
  • 12 Kawasaki T, Taniuchi Y, Hisamichi N. et al. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation. Biochem J 1995; 308: 947-53.
  • 13 Chen YL, Tsai IH. Functional and sequence characterization of agkicetin, a new glycoprotein Ib antagonist isolated from Agkistrodon acutus venom. Biochem Biophys Res Commun 1995; 210: 472-7.
  • 14 Fukuda K, Mizuno H, Atoda H. et al. Crystal structure of flavocetin-A, a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers. Biochemistry 2000; 39: 1915-23.
  • 15 Kawasaki T, Fujimura Y, Usami Y. et al. Complete amino acid sequence and identification of the platelet glycoprotein Ib-binding site of jararaca GPIb-BP, a snake venom protein isolated from Bothrops jararaca . J Biol Chem 1996; 271: 10635-9.
  • 16 Clemetson KJ. Platelet GPIb-V-IX complex. Thromb Haemost 1997; 78: 266-70.
  • 17 Andrews RK, Lopez JA, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997; 29: 91-105.
  • 18 Andrews RK, Berndt MC. Adhesion-dependent signalling and the initiation of haemostasis and thrombosis. Histol Histopathol 1998; 13: 837-44.
  • 19 Ware J. Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 1998; 79: 466-78.
  • 20 Andrews RK, Shen Y, Gardiner EE. et al. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 1999; 82: 357-64.
  • 21 Berndt MC, Shen Y, Dopheide SM. et al. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86: 178-88.
  • 22 Li Z, Xi X, Du X. A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin αIIbβ3 . J Biol Chem 2001; 276: 42226-32.
  • 23 Jy W, Horstman LL, Park H. et al. Platelet aggregates as makers of platelet activation: characterization of flow cytometric method suitable for clinical applications. Am J Hematol 1998; 57: 33-42.
  • 24 Shattil SJ, Cunningham M, Hoxie JA.. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-15.
  • 25 Adelman B, Michelson AD, Handin RI. et al. Evaluation of platelet glycoprotein Ib by fluorescence flow cytometry. Blood 1985; 66: 423-7.
  • 26 Huang TF, Sheu JR, Teng CM. A potent anti-platelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem J 1991; 277: 351-7.
  • 27 Wu WB, Peng HC, Huang TF. Crotalin, a vWF and GPIb cleaving metalloproteinase from venom of Crotalus atrox . Thromb Haemost 2001; 86: 1501-11.
  • 28 Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985; 76: 101-8.
  • 29 Coller BS, Peerschke EI, Scudder LE. et al. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110.
  • 30 Pidard D, Montgomery RR, Bennett JS. et al. Interaction of AP2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-6.
  • 31 Newman PJ, Allen RW, Kahn RA. et al. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood 1985; 65: 227-32.
  • 32 Okita JR, Pidard D, Newman PJ. et al. On the association of glycoprotein Ib and actin-binding protein in human platelets. J Cell Biol 1985; 100: 317-21.
  • 33 Handa M, Titani K, Holland LZ. et al. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib-characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986; 261: 12579-85.
  • 34 Chen YL, Tsai KW, Chang T. et al. Glycoprotein Ib-binding protein from the venom of Deinagkistrodon acutus- cDNA sequence, functional characterization, and three-dimensional modeling. Thromb Haemost 2000; 83: 119-126.
  • 35 Mustard JF, Perry DW, Ardlie NG. et al. Preparation of suspension of washed platelet from humans. Br J Haematol 1972; 122: 193-204.
  • 36 Kirby EP, Mills DCB. The interaction of bovine factor VIII with human platelets. J Clin Invest 1975; 56: 491-502.
  • 37 Von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem 1983; 133: 17-21.
  • 38 Leduc M, Bon C. Cloning of subunits of convulxin, a collagen-like platelet-aggregating protein from Crotalus durissus terrificus venom. Biochem J 1998; 333: 389-93.
  • 39 Weis WI, Kahn R, Fourme R. et al. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science 1991; 254: 1608-15.
  • 40 Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992; 360: 127-34.
  • 41 Kroll M H, Hellums JD, Guo Z. et al. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 1993; 268: 3520-4.
  • 42 Bertolino G, Noris P, Spedini P. et al. Ristocetin-induced platelet agglutination stimulates GPIIb/IIIa-dependent calcium influx. Thromb Haemost 1995; 73: 689-92.
  • 43 Mazzucato M, Pradella P, Cozzi MR. et al. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibα mechanoreceptor. Blood 2002; 100: 2793-800.
  • 44 Simon DI, Chen Z, Xu H. et al. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
  • 45 Cauwenberghs N, Vanhoorelbeke K, Vauterin S. et al. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibα. Blood 2001; 98: 652-60.
  • 46 Dormann D, Clemetson JM, Navdaev A. et al. Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. Blood 2001; 97: 929-36.